The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. uri icon

authors

  • Nassif, Michael E
  • Umpierrez, Guillermo
  • Lamba, Sumant
  • Sharma, Kavita
  • Khan, Sadiya S
  • Chandra, Lokesh
  • Gordon, Robert A
  • Ryan, John J
  • Chaudhry, Sunit-Preet
  • Joseph, Susan M
  • Chow, Chen H
  • Windsor, Sheryl L
  • Kanwar, Manreet K
  • Pursley, Michael
  • Siraj, Elias S
  • Lewis, Gregory D
  • Clemson, Barry S
  • Fong, Michael
  • Kosiborod, Mikhail N
  • Borlaug, Barry A
  • Dalane W Kitzman, MD
  • Shah, Sanjiv J
  • Tang, Fengming
  • Khariton, Yevgeniy
  • Malik, Ali O
  • Khumri, Taiyeb

publication date

  • January 1, 2021